With second-quarter net revenues up 7.4% to $37.2 billion, CVS Health shows no signs of slowing down. It posted earnings of $1.22 per share, beating Zacks Investment Research analyst consensus of $1.20 per share. “On an underlying basis, we surpassed the high end of our guidance range by two cents, as operating profit in the retail business exceeded our expectations while operating profit in the PBM was in line with our guidance,” CVS Health president and CEO Larry Merlo said.